Evidence map›Paper›PMID 31561578›Full record

ReviewPharmaceutics2019

Silk Fibroin as a Functional Biomaterial for Drug and Gene Delivery.

Mhd Anas Tomeh, Roja Hadianamrei, Xiubo Zhao

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 186 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Silk protein plastics for sustained and controlled drug release.International journal of pharmaceutics · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Advances in Nano-Immunomodulatory Systems for the Treatment of Acute Kidney Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Mhd Anas TomehDepartment of Chemical and Biological Engineering, University of Sheffield, Sheffield S1 3JD, UK. matomeh1@sheffield.ac.uk.
Roja HadianamreiDepartment of Chemical and Biological Engineering, University of Sheffield, Sheffield S1 3JD, UK. rhadianamrei1@sheffield.ac.uk.
Xiubo ZhaoDepartment of Chemical and Biological Engineering, University of Sheffield, Sheffield S1 3JD, UK. xiubo.zhao@sheffield.ac.uk.ORCID 0000-0002-4620-2893
University of Sheffield · GBChangzhou University · CN

Funding

TRANSFORMATION OF B LYMPHOCYTES BY EPSTEIN-BARR VIRUSF32CA007174 · NCI · DANA-FARBER CANCER INSTITUTE · PI SPECK, SAMUEL H · 1985 to 1985
–
Engineering and Physical Sciences Research Council EP/N007174/1 and EP/N023579/1Royal Society RG160662
6 · The paper itself

Abstract

Silk is a natural polymer with unique physicochemical and mechanical properties which makes it a desirable biomaterial for biomedical and pharmaceutical applications. Silk fibroin (SF) has been widely used for preparation of drug delivery systems due to its biocompatibility, controllable degradability and tunable drug release properties. SF-based drug delivery systems can encapsulate and stabilize various small molecule drugs as well as large biological drugs such as proteins and DNA to enhance their shelf lives and control the release to enhance their circulation time in the blood and thus the duration of action. Understanding the properties of SF and the potential ways of manipulating its structure to modify its physicochemical and mechanical properties allows for preparation of modulated drug delivery systems with desirable efficacies. This review will discuss the properties of SF material and summarize the recent advances of SF-based drug and gene delivery systems. Furthermore, conjugation of the SF to other biomolecules or polymers for tissue-specific drug delivery will also be discussed.

Indexed as

bioconjugationcontrolled releasedrug deliverygene deliverysilk fibroin

Identifiers

PMID31561578
PMCPMC6835371
OpenAlexW2976274973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.